1. Introduction {#sec1-healthcare-04-00075}
===============

The World Health Organization identified cardiovascular disease (CVD) as the leading worldwide cause of mortality (46.2%) in 2012. Dietary intakes are a modifiable risk factor for CVD \[[@B1-healthcare-04-00075],[@B2-healthcare-04-00075]\] with dietary patterns, such as the Mediterranean diet shown to reduce incidence of cardiovascular events within five years of adhering to the pattern \[[@B3-healthcare-04-00075]\]. The United States Preventive Services Task Force deemed the likelihood of harm to be small to none for dietary modification, with adequate evidence of benefits from intensive counselling in populations with multiple risk factors for CVD \[[@B2-healthcare-04-00075]\].

However, achieving dietary change in populations at increased risk of CVD can be difficult \[[@B4-healthcare-04-00075],[@B5-healthcare-04-00075]\]. Barriers to implementation of dietetic counselling include the time and cost of multiple dietetic consultations for those at risk, as well as reluctance of medical practitioners to refer at risk patients if the practitioner believes the patient is unwilling or unable to attend dietetic consultations or that medication is going to be as effective \[[@B6-healthcare-04-00075]\]. Evidence for the effectiveness of less intensive dietary interventions, i.e., fewer consultations, is lacking and trials assessing such approaches are needed \[[@B2-healthcare-04-00075]\]. Given these barriers and lack of evidence for the effectiveness of brief interventions, a study design more pragmatic than explanatory may be of value. Pragmatic study designs mimic or are suitable for normal practice, use participants that would typically be receiving the treatment, and target outcomes relevant to the stakeholders: i.e., the patients, general practitioners and healthcare providers \[[@B7-healthcare-04-00075]\].

Key components of behavioural interventions shown to contribute to effectiveness include individualised assessment, goal setting, education and feedback, and provision of written information to reference as verbal information is commonly forgotten or incorrectly recalled \[[@B8-healthcare-04-00075],[@B9-healthcare-04-00075],[@B10-healthcare-04-00075]\]. Also, provision of food items or subsidising healthier food products have been shown to be effective in weight-loss interventions and in modifying dietary behaviours \[[@B11-healthcare-04-00075],[@B12-healthcare-04-00075]\].

The aim of the current study was to trial the effectiveness of a brief dietetic intervention on diet-related CVD risk factors in hyperlipidaemic adults. The intervention translated the best-available dietary evidence into a manual for participants and included targeted feedback and individualised CVD-health counselling strategies in a single session provided by an Accredited Practising Dietitian (APD). It was hypothesised that the dietetic intervention would improve lipid profiles.

2. Materials and Methods {#sec2-healthcare-04-00075}
========================

2.1. Study Design {#sec2dot1-healthcare-04-00075}
-----------------

The study was a pre-post dietary intervention in hyperlipidaemic adults. The study protocol is summarised in [Figure 1](#healthcare-04-00075-f001){ref-type="fig"}. Participants completed the Australian Eating Survey (AES) food frequency questionnaire and provided a fasting blood sample for analysis prior to attending a single dietetic counselling session where they received personalised feedback on their current diet, CVD risk, and counselling on dietary strategies. The dietary advice focused on evidence from the Mediterranean and Portfolio diets, which have been shown to be effective in lowering CVD events and risk factors \[[@B3-healthcare-04-00075],[@B13-healthcare-04-00075]\]. A study-specific education manual was provided to assist participants adopt the recommended eating patterns. Assessments of diet (24-hour recalls) and CVD risk (blood lipids, blood pressure, anthropometric measures) were conducted prior to counselling and after a minimum 6 weeks follow-up, at the participant's convenience (see [Supplementary Figure S1](#app1-healthcare-04-00075){ref-type="app"}: study timeline). Primary outcome measures were dietary changes and plasma total cholesterol.

2.2. Participants {#sec2dot2-healthcare-04-00075}
-----------------

Individuals were eligible to participate if they were aged between 18--75 years, had internet access, were not on lipid lowering medication and had one or more of the following: low density lipoprotein (LDL) cholesterol ≥ 4.00 mmol/L; total:HDL (high density lipoprotein) ratio ≥ 5; total cholesterol ≥ 5.00 mmol/L \[[@B14-healthcare-04-00075]\]. Participants currently on medication for hyperlipidaemia were eligible if their treating medical practitioner provided written clearance to halt medication for the duration of the study, and participants undertook a six-week washout period. Those with medical conditions affecting dietary intake (such as coeliac disease) or requiring medication for thyroid conditions were excluded. Written consent was obtained from all participants. Ethics approval was obtained from the University of Newcastle Human Research Ethics Committee (H-2013-0420). Participants were recruited via media releases from the University of Newcastle and the Hunter Medical Research Institute (HMRI), advertising on notice boards within the university setting, invitations through the HMRI volunteer research register, and by word of mouth.

2.3. Dietary Assessments {#sec2dot3-healthcare-04-00075}
------------------------

Online questionnaires were used to obtain demographic data, health characteristics, usual dietary intake and preferences for food products related to CVD health. These were completed by participants at their convenience, prior to the dietary intervention. To inform dietary feedback and counselling, usual dietary intakes over the last 6 months were derived from the Australian Eating Survey (AES) \[[@B15-healthcare-04-00075],[@B16-healthcare-04-00075]\]. The AES is a validated 120 item semi-quantitative food frequency questionnaire (FFQ) that assesses frequency of usual intake over the past six months \[[@B15-healthcare-04-00075],[@B16-healthcare-04-00075]\]. AES nutrient intakes were computed using FoodWorks version 4.00.1158 (FoodWorks, Xyris Software (Australia) Pty Ltd., Ashwood, Australia, 2005), the Australian AusNut 1999 nutrient database (All Foods, Revision 17) and AusFoods (Brands, Revision 5).

To determine intervention effects on diet, dietary intake was assessed using a three-pass 24-hour recall on two occasions (one weekend day; one week day) at both baseline and follow-up, and was performed by one researcher (Tracy Schumacher) \[[@B17-healthcare-04-00075],[@B18-healthcare-04-00075],[@B19-healthcare-04-00075]\]. Prior to baseline dietary assessment, each participant was issued with a booklet of two dimensional food models that included a reference scale to assist with portion size estimation. Entries obtained from 24-hour recalls were matched to a food from the AUSNUT 2011--2013 food nutrient database by one research dietitian and assessed for comparability by another. Foods not found in the database were matched to foods of similar nutrient content. Quantities were converted to gram measures using values from the AUSNUT food measures database where necessary \[[@B20-healthcare-04-00075],[@B21-healthcare-04-00075]\]. Energy-dense, nutrient-poor foods, or discretionary food items, were defined according to the Australian Dietary Guidelines and individually categorised using the Australian Health Survey discretionary food list \[[@B22-healthcare-04-00075]\]. Examples of discretionary foods include most sweetened biscuits, foods high in saturated fat, salt or sugar. Nutrient intake values for 24-hour recalls were calculated using Stata/IC 13.1 by multiplying gram measures by nutrient values for each individual food \[[@B23-healthcare-04-00075]\]. Timing of dietary assessments can be seen in [Supplementary Figure S1](#app1-healthcare-04-00075){ref-type="app"}: Study timeline.

2.4. Clinical and Anthropometric Assessments {#sec2dot4-healthcare-04-00075}
--------------------------------------------

All clinical and anthropometric measures were collected at the time of the face-to-face intervention. Blood samples collected after an overnight fast were assayed for blood lipid concentrations, glucose, insulin and inflammatory markers at an accredited pathology service laboratory (National Association of Testing Authorities, Newcastle, Australia) at baseline and follow-up. Insulin was measured and HOMA IR calculated only at baseline, unless a result ≥ 10 mIU/L was found. Brachial and central blood pressure and arterial stiffness measures (augmentation index) were obtained with the Pulsecor Cardioscope II (Pulsecor Ltd., Auckland, New Zealand) using WelchAllyn FlexiPort reusable blood pressure cuffs. Participants were seated for five minutes before the first measurement occurred and repeat measures were taken at two-minute intervals until two consistent measures were obtained. Participants' height and weight were measured in light clothing to 0.1 cm and 0.1 kg, respectively using the Biospace BSM370 Automatic BMI Scale Stadiometer (Biospace Co. Ltd., Seoul, Korea) and used to calculate body mass index (BMI, kg/m^2^). Waist circumference was measured at the narrowest point between the lower costal (10th rib) border and the top of the iliac crest using a non-extensible steel tape (KDFS10-02, KDS Corporation, Osaka, Japan). Physical activity was assessed using the International Physical Activity Questionnaire (IPAQ) long form for the previous seven days \[[@B24-healthcare-04-00075],[@B25-healthcare-04-00075]\].

2.5. Intervention {#sec2dot5-healthcare-04-00075}
-----------------

The intervention was based on a Protection Motivation Theory (PMT) framework, which describes health behaviours as responses to perceptions of threats of vulnerability and their severity \[[@B26-healthcare-04-00075]\]. The theory posits that individuals determine the benefits and/or usefulness of performing adaptive (helpful) or mal-adaptive (harmful) behaviours, then assess their confidence to perform the given action \[[@B26-healthcare-04-00075]\]. The study sought to use awareness of personal CVD risk as motivation and integration of behaviour change strategies to build self-efficacy for helpful dietary intake tasks, such as increasing fish and reducing energy-dense, nutrient-poor foods, and to provide meaningful feedback on performing the recommended strategies.

Following baseline assessments, written feedback was provided in the form of a booklet, including the individual's serum cholesterol results, anthropometric measures, and analysis of their usual dietary intake. Dietary feedback included macronutrient and micronutrient intakes, and percentage of energy contributed by core (nutrient dense) and energy-dense, nutrient-poor foods. Verbal feedback was provided in regard to CVD risk factors identified, such as serum lipids, and was linked to dietary intake. Dietetic counselling immediately followed in a 45-minute session, which used a semi-structured presentation to ensure consistent delivery of the dietary components and goal setting strategies, whilst allowing for individualised counselling by the APD (see [Table 1](#healthcare-04-00075-t001){ref-type="table"}). Participants were educated about a range of dietary components that had been demonstrated to reduce CVD risk and informed about heart healthy eating guidelines \[[@B3-healthcare-04-00075],[@B13-healthcare-04-00075],[@B27-healthcare-04-00075],[@B28-healthcare-04-00075]\]. Participants were free to choose goals from among the dietary components presented (see [Table 1](#healthcare-04-00075-t001){ref-type="table"}). The Mediterranean diet is characterised by a high monounsaturated:saturated fat ratio, high intakes of legumes, fruits, vegetables, wholegrains, minimally processed cereals, regular intakes of fish and nuts, low intakes of red meats, and moderate intakes of dairy and alcohol \[[@B3-healthcare-04-00075],[@B29-healthcare-04-00075],[@B30-healthcare-04-00075]\]. The Portfolio diet is a predominantly vegetarian diet with the addition of plant-based foods with lipid-lowering properties such as plant sterols, soy and vegetable protein, nuts and soluble fibres \[[@B13-healthcare-04-00075]\]. Additional resources included a nutrition education manual specifically designed to complement and extend the dietary information delivered as part of the intervention and included supplementary detail, food guides and recipes for targeted foods. Participants also received a grocery bag containing samples of shelf-stable recommended food products valued at approximately \$50 AUD. This was to encourage participants to try foods that were not part of their usual diet, such as soy milk, low-sodium canned beans/legumes and canned oily fish. In the week following the intervention, participants received one follow-up phone call (approximately 10 minutes) from the APD to discuss progress and to troubleshoot any difficulties faced.

Participants were provided with feedback on their dietary intake and physical changes, such as blood pressure and weight at the face-to-face follow-up assessment session. Individual results of the post-intervention blood biomarker analyses were provided to participants via telephone when available.

2.6. Statistics {#sec2dot6-healthcare-04-00075}
---------------

A sample size of 33 participants was required to detect a 0.4 mmol/L change in the primary outcome measure of total cholesterol, based on a standard deviation of 0.8, power of 80% and an alpha of 0.05 \[[@B33-healthcare-04-00075]\]. Allowing for 20% loss to follow-up, the study aimed to recruit 40 participants. Data were analysed as intention-to-treat by mixed model linear regression using Stata/IC 13.1 \[[@B23-healthcare-04-00075]\]. Analyses for total cholesterol, HDL and total:HDL ratio were adjusted for sex, BMI and physical activity. Analyses for triglycerides, LDL cholesterol, inflammation markers, glucose, blood pressure, and augmentation index were adjusted for sex and BMI. Analyses for dietary measures were adjusted for recall on weekend/weekday and sex, with percentage energy values adjusted for weekend/weekday recall only. Alcohol was tested in lipid analyses where it may have had an effect, and potentially removed in a backward stepwise approach, if inclusion in the model did not improve the data fit and removal did not change the coefficients. Categorical data were analysed by using multinomial logistic regression, with standard errors adjusted for clustering to account for multiple time points.

3. Results {#sec3-healthcare-04-00075}
==========

Participant flow through the trial is summarised in [Figure 1](#healthcare-04-00075-f001){ref-type="fig"}, with 42 participants eligible and 39 participating in the intervention from February to December 2014. Time between baseline and follow-up was (mean ± SD) 9.5 ± 2.5 weeks. Participants were aged 59.3 ± 11.1 years (range 25--73), 72% female, 28, had completed education to higher than Year 10 or equivalent, and 18 had household incomes below \$1000 AUD per week. Six participants discontinued their lipid-lowering medication prior to starting the trial, with one restarting after baseline results (follow-up lipid results excluded from analysis). Thirty-four participants reported one or more health conditions: high cholesterol (n = 27), high blood pressure (n = 13), arthritis (n = 10), depression (n = 4), asthma (n = 3), type 1 and 2 diabetes (n = 1 each). No participants were current smokers, but 20 were former smokers. Physical activity levels were categorised by IPAQ as low (n = 6), moderate (n = 21) or high (n = 12) at baseline and low (n = 4), moderate (n = 24) or high (n = 10) at follow-up.

[Table 2](#healthcare-04-00075-t002){ref-type="table"} summarises baseline, follow-up, and changes in CVD health indicator measures. Significant post-intervention reductions in triglycerides, LDL and total cholesterol, total:HDL cholesterol ratio were observed, including a small reduction in HDL cholesterol. For serum lipids, total cholesterol decreased by 7%, LDL-C by 6% and HDL by 3%, while the ratio of HDL:total cholesterol decreased by 5% and triglycerides by 24%. Significant reductions in BMI, waist circumference and brachial blood pressure were also observed. No change was seen in inflammatory markers (high sensitivity C-reactive protein) or liver function (ALT, AST, GGT).

[Table 3](#healthcare-04-00075-t003){ref-type="table"} summarises dietary intake measured by 24-hour recalls, indicating a substantial reduction in the proportion of energy from energy-dense, nutrient-poor foods. Macronutrient contributions remained relatively stable, although small but significant changes were found in protein, saturated and polyunsaturated fat, and sodium intakes. Fruit and vegetable intakes remained sub-optimal relative to national recommendations.

[Table 4](#healthcare-04-00075-t004){ref-type="table"} indicates that some dietary habits related to CVD health, such as using reduced fat cheese, were amendable to change (*p* \< 0.01).

4. Discussion {#sec4-healthcare-04-00075}
=============

Significant reductions in CVD risk factors were achieved through dietary changes implemented by hyperlipidaemic adults following a brief dietetic intervention by an APD based on individualised feedback and advice. Key intervention components were prior assessment of dietary intake using a purpose-designed online questionnaire and access to current blood lipid results so that the single counselling session could be personally targeted, with a focus on providing feedback and education, with support via purposed designed resources. Results suggest that a brief dietetic intervention, suitable for widespread use in primary care settings, can have a valuable impact on diet-related CVD risk factors.

Participants improved overall serum lipid profiles, which can be attributed to dietary change, given that other confounding variables, such as physical activity, medication and smoking status were accounted for in the statistical analysis. Findings from the Cholesterol Treatment Trialists' Collaboration indicated that a 1.00 mmol/L reduction in serum LDL cholesterol following statin prescription reduced the major vascular events rate ratio by 0.62, 0.69 and 0.79 in those at \< 5%, ≥ 5 to \< 10% and ≥ 10 to \< 20% five-year risk, respectively \[[@B37-healthcare-04-00075]\]. An additional benefit of achieving reductions in LDL cholesterol secondary to dietary change is the concomitant reduction in risk for other chronic conditions \[[@B38-healthcare-04-00075]\]. Reductions in LDL (6%) and total cholesterol (7%) in the current study are similar to those achieved using a single-session community-based intervention by Gaetke et al., where participants were free to choose their own food based on advice provided \[[@B39-healthcare-04-00075]\], but were less than the 26% and 34% reductions reported by Tovar et al. in an intervention that specified menu plans and provided prescribed foods \[[@B40-healthcare-04-00075]\].

The dietary change responsible for the greatest reduction in energy intake in the current study was the reduction in energy-dense, nutrient-poor food consumption from 32% of total energy at baseline to 24% at follow up. Increased intakes of core foods were small and individually variable. There were no group differences in intakes of recommended foods, such as fruit and vegetables, and only small increases in legumes and soy. The significant increases in soy and plant sterol containing foods indicate that many were willing to increase intakes of these foods, but further strategies are needed to reach the recommended efficacious levels \[[@B41-healthcare-04-00075],[@B42-healthcare-04-00075],[@B43-healthcare-04-00075]\]. There were no significant group level improvements in reported intakes of nuts, fish, fruit, fibre from oats/psyllium/linseed or vegetables. However, with the exception of vegetables, for which legumes may have been substituted, the point estimates were in the direction of improvement. Individual participants made changes in some but not all of the food recommendations, and this varied based on personal preferences and baseline consumption. The current study provides evidence for the cumulative benefit of multiple small improvements in intakes of foods with known cardio-protective effects being sufficient to provide CVD-risk protection, even though individual food changes were not detected as statistically significant.

The PREDIMED study was a large scale intervention that provided evidence of the long-term impact of a Mediterranean style eating pattern on the primary prevention of CVD \[[@B3-healthcare-04-00075]\]. Total fat intakes (33% energy) of those in the current study were substantially less than those in the PREDIMED study (41% post-trial), although they were still higher than Australian adults at 31% \[[@B3-healthcare-04-00075],[@B44-healthcare-04-00075]\]. Consequently there were slightly higher protein (3%) and carbohydrate (3%) intakes compared to PREDIMED. Total fibre intakes in the current study were adequate, although the types of foods consumed were unlikely to contain the level or viscosity of soluble fibres required to reduce risk factors for CVD \[[@B45-healthcare-04-00075],[@B46-healthcare-04-00075]\]. Future quantification of soluble and insoluble fibre intakes could be a valuable tool to use in personalised feedback for those at elevated risk of CVD.

Strengths of the current study include the provision of specific, targeted and individually tailored feedback by a dietitian, made possible through the prior online assessment of dietary intake, provision of current blood lipid results, and an educational counselling session supplemented by a purpose-designed nutrition education manual. Feedback related the individual's current intakes to appropriate reference ranges and suggested targets in both written and verbal forms, allowing participants time to ask questions and consider results. The use of the Protection Motivation Theory as the intervention framework was appropriate, as participants self-identified as having high serum cholesterol levels (threat vulnerability) and were counselled to achieve self-efficacy through behavioural techniques ([Table 1](#healthcare-04-00075-t001){ref-type="table"}).

Limitations of the current study include the pragmatic study design, relatively small sample size and hence risk of type 2 error. An explanatory study design, such as a randomised controlled trial, may have increased internal validity and given greater proof of causality. However, this study has informed power calculations for future intervention sample sizes, with the primary outcome based on changes in percentage energy of discretionary food choices. The study design was also not truly pragmatic, as an intervention suitable for everyday practice would not have been able to provide shelf-stable grocery products to induce experimentation with unfamiliar products. Given that the greatest dietary change was an approximate 1000 kJ/day reduction in discretionary food choices, experimentation with food choices as a behaviour change may not necessarily be of high value in a brief intervention. Changes in foods recommended for consumption several times a week, such as fish, may not have been accurately captured using the 24-hour recall dietary method, even though both a weekday and weekend day were assessed at each time point. It is possible that this also impacted on legume intake given that they may not be consumed every day \[[@B47-healthcare-04-00075]\]. Misreporting is common when assessing dietary intake, although changes in biochemical variables and reduction in BMI in the current study provide support for the relative accuracy of reported dietary intakes \[[@B48-healthcare-04-00075]\]. Although the age of the study population reflects those with elevated LDL cholesterol levels within the general population and heart disease currently has the highest mortality rate for women in Australia, this sample was overly represented by females relative to males \[[@B49-healthcare-04-00075],[@B50-healthcare-04-00075]\]. Moderating contextual factors include the university setting leading to an inherent higher level of trust in the dietary advice, and the majority of participants being recruited from a research volunteer register, hence potentially more likely to comply with recommendations. The number of contacts due to dietary recalls and screening for study entry meant that a relationship was already established between the dietitian and participant, thereby decreasing the time needed for this during the counselling session. The short time-frame is both a strength and a limitation of the current study. The minimum six-week period was sufficient to achieve clinically important changes in plasma lipids, as well as demonstrate to study participants the efficacy of their dietary intervention, based on the short-term dietary changes that they made in that time period. However, these results cannot be generalised into longer-term behaviour changes.

5. Conclusions {#sec5-healthcare-04-00075}
==============

These findings support the usefulness of including well-structured dietetic counselling by APDs as an initial approach to manage increased risk of CVD conferred by diet. Participants significantly reduced their intakes of energy-dense, nutrient-poor foods, although few significant changes were seen in intakes of specific foods associated with serum lipid reduction. Individuals with hyperlipidaemia can make cumulative small changes to their diet based on the personalised feedback leading to improved CVD risk markers. Recommendations for future practice include utilising validated methods of assessing usual intake prior to counselling sessions in this population and use of behaviour change strategies in tailored interventions for individuals.

Ethics approval was from University of Newcastle Human Research Committee, H-2013-0420. This study was supported by the Hunter Medical Research Institute (HMRI 13-46). Neil J. Spratt was supported by an Australian National Health and Medical Research Council Career Development Fellowship, APP1035465. The researchers wish to acknowledge the support of the HMRI Research Volunteer Register for their assistance in participant recruitment.

The following are available online at [www.mdpi.com/2227-9032/4/4/75/s1](www.mdpi.com/2227-9032/4/4/75/s1), Figure S1: Study timeline.
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healthcare-04-00075-t001_Table 1

###### 

Foods recommended and behaviour change strategies incorporated in the intervention. Foods targeted for dietary knowledge were informed by evidence for reducing cardiovascular disease (CVD) risk \[[@B3-healthcare-04-00075],[@B28-healthcare-04-00075]\] or improving serum lipids \[[@B13-healthcare-04-00075]\].

  ---------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
  **Dietary Knowledge**                                      **Quantity**                                                                                                                                                                  **Example Foods**
  Nuts                                                       25--30g/day                                                                                                                                                                   Unsalted almonds, walnuts
  Fish and omega 3 fats                                      2--3 serves/week                                                                                                                                                              Fresh/canned salmon or tuna
  Soy proteins                                               Up to 7 serves/day                                                                                                                                                            Soy milk, tofu, tempeh
  Lentils and legumes                                        Up to 7 serves/week                                                                                                                                                           Kidney beans, lentils, chick peas
  Soluble fibre                                              Up to 15g/day                                                                                                                                                                 Psyllium husk, oat bran, fruit, vegetables
  Plant sterols                                              2--3 serves/day                                                                                                                                                               Margarines/milk/cheese with added sterols
  Healthy eating                                             As given by the Australian Guide to Healthy Eating \[[@B31-healthcare-04-00075]\]                                                                                             
  **Behavioural technique \[[@B32-healthcare-04-00075]\]**   **Illustration from intervention**                                                                                                                                            
  Provide information about behaviour-health link            General information given about the types of foods and nutrients that increase blood triglyceride levels                                                                      
  Prompt intention formation                                 Participants were provided with pantry items of recommended foods and recipes for their use                                                                                   
  Prompt specific goal setting                               Participants were required to generate three specific personal goals                                                                                                          
  Provide instruction                                        All participants were provided with 63-page resource manual with recommended serving sizes of food groups and food preparation methods                                        
  Model or demonstrate the behaviour                         Study participants were given breakfast upon completion of fasting study measures, with choices offered from a menu of items consistent with the recommended dietary advice   
  Provide feedback on performance                            Participants were given dietary feedback based on analysis of current intake                                                                                                  
  ---------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------

\* Other behaviour change techniques such as relapse prevention, time management or prompt barrier identification, may have been incorporated within the individual counselling session dependent on needs identified by Accredited Practising Dietitian.

healthcare-04-00075-t002_Table 2

###### 

Pre- and post-intervention cardiovascular risk factors impacted by dietary intervention. Data reported as mean ± standard deviation, with 95% confidence intervals (CI) for change as given by the coefficient of the regression.

  Risk Factors                         (Reference Range ^1^)               Baseline (n = 39)   Follow up (n = 38)   Change   95% CI         *p* Value
  ------------------------------------ ----------------------- ----------- ------------------- -------------------- -------- -------------- -----------
  *Anthropometry*                                                                                                                           
  BMI                                                          (kg/m^2^)   28.1 ± 5.7          27.6 ± 5.7           −0.4     −0.7, −0.2     \<0.01
  Weight                                                       (kg)        77.8 ± 17.6         76.3 ± 17.5          −1.3     −1.9, −0.7     \<0.01
  Waist circumference                                          \(cm\)      92.3 ± 15.9         90.2 ± 14.5          −1.5     −2.3, −0.7     \<0.01
  Blood pressure ^2^                                           (mmHg)                                                                       
  *Brachial*                                                                                                                                
  Systolic                                                                 125.9 ± 17.2        121.1 ± 16.0         −4.8     −8.3, −1.2     \<0.01
  Diastolic                                                                75.9 ± 7.3          73.2 ± 8.6           −2.4     −4.1, −0.7     \< 0.01
  *Central*                                                                                                                                 
  Systolic                                                                 120.2 ± 17.0        116.6 ± 14.7         −3.6     −7.5, 0.2      0.07
  Diastolic                                                                77.2 ± 7.3          75.0 ± 8.7           −2.0     −4.0, 0.4      0.06
  Augmentation index                                                       108.4 ± 56.8        99.8 ± 34.8          −9.6     −23.1, 3.9     0.16
  Fasting Serum CVD risk markers ^3^                                                                                                        
  Lipids                                                                                                                                    
  Triglycerides                        \< 1.5                  (mmol/L)    1.60 ± 1.27         1.19 ± 0.51          −0.38    −0.73, −0.03   0.03
  Total cholesterol                    \< 4.00                 (mmol/L)    6.79 ± 1.10         6.27 ± 1.00          −0.51    −0.77, −0.24   \<0.01
  LDL cholesterol                      \< 2.5                  (mmol/L)    4.60 ± 1.04         4.30 ± 0.97          −0.29    −0.52, −0.05   0.02
  HDL cholesterol                      \> 1.0                  (mmol/L)    1.46 ± 0.34         1.43 ± 0.35          −0.05    −0.10, −0.00   0.05
  Total:HDL ratio                                                          5.02 ± 1.96         4.63 ± 1.44          −0.27    −0.51, −0.04   0.02
  Inflammation markers                                                                                                                      
  *hsCRP*                              \< 5.0                  (mg/L)      2.25 ± 2.26         2.22 ± 2.23          0.1      −0.40, 0.60    0.70
  *ALT*                                0--45                   (U/L)       25.9 ± 15.1         27.8 ± 14.7          2.0      −0.1, 4.1      0.07
  *AST*                                0--41                   (U/L)       25.9 ± 5.9          27.6 ± 7.1           1.9      −0.5, 4.2      0.12
  *GGT*                                0--45 (F) 0--70 (M)     (U/L)       32.5 ± 37.0         30.1 ± 29.5          −1.1     −5.2, 3.1      0.62
  BGL                                  3.0--6.0                (mmol/L)    5.16 ± 0.57         4.94 ±0.59           −0.20    −0.32, −0.08   \<0.01
  HOMA IR score ^4^                                            (mmol/L)    1.04 ± 0.74                                                      

^1^ Reference range (Australian) \[[@B34-healthcare-04-00075],[@B35-healthcare-04-00075]\]; ^2^ Model includes sex and BMI; ^3^ n = 37 at follow up (n = 1 resumed lipid medication). Models include sex and BMI. PA included in HDL models; ^4^ n = 36 (based on HOMA2 calculations; n = 2 insulin values too low for calculation validity \[[@B36-healthcare-04-00075]\]). Abbreviations: BGL, blood glucose level; BMI, body mass index; Coef., Coefficient; F, females; HDL, high density lipoprotein; LDL, low density lipoprotein; M, males; Reference, reference range.

healthcare-04-00075-t003_Table 3

###### 

Pre- and post-intervention dietary intakes of hyperlipidaemic participants as obtained by 24-hour recall. Data presented as mean ± standard deviation and 95% confidence interval for change as given by regression coefficient. Foods specific cardiovascular health also given.

                                                 Baseline (n = 39)   Follow up (n = 38)   Change ^1^   95% CI        *p* Value
  ---------------------------------------------- ------------------- -------------------- ------------ ------------- -----------
  Total energy (kJ/day)                          9580 ± 2695         8712 ± 2614          −870         −1611, −130   0.02
  Discretionary energy (kJ/day) ^2^              3231 ± 2058         2223 ± 1821          −1006        −1563, −450   \<0.001
  \% Discretionary energy                        31.7 ± 16.6         24.1 ± 15.1          −7.5         −12.4, −2.7   \< 0.01
  \% Protein                                     17.4 ± 4.4          18.9 ± 4.6           1.5          0.1, 2.9      0.04
  \% CHO                                         45.0 ± 10.0         43.6 ± 9.9           −1.4         −4.4, 1.6     0.35
  \% Fats                                        33.6 ± 8.7          32.9 ± 9.7           −0.7         −3.7, 2.3     0.64
  \% sat. fat                                    11.4 ± 4.0          9.8 ± 4.5            −1.5         −2.9, −0.2    0.03
  \% mono. fat                                   13.5 ± 5.2          12.9 ± 5.2           −0.6         −2.4, 1.2     0.50
  \% poly. fat                                   6.0 ± 2.9           7.2 ± 2.8            1.3          0.46, 2.1     \<0.01
  Fibre (g)                                      29.2 ± 10.2         29.3 ± 10.0          0.1          −2.2, 2.5     0.91
  Sodium (mg)                                    2764 ± 1397         2410 ± 1184          −358         −650, −67     0.02
  Foods specific to cardiovascular health                                                                            
  Fruit serves/day ^3^                           0.85 ± 0.89         0.97 ± 99            0.12         −0.13, 0.37   0.36
  Vegetable serves/day ^3^                       3.18 ± 2.83         3.05 ± 2.47          −0.13        −0.80, 0.53   0.69
  Nuts (g/day)                                   16.3 ± 32.3         17.6 ± 25.6          1.2          −7.7, 10.2    0.79
  Fish (g/day)                                   29.4 ± 62.9         44.0 ± 68.4          13.5         −5.4, 32.5    0.16
  Soy proteins (g/day) ^4^                       1.0 ± 2.9           2.9 ± 4.3            2.0          0.8, 3.3      0.001
  Legumes (g/day)                                8.3 ± 28.0          20.9 ± 54.4          12.6         −0.53, 25.8   0.06
  Fibre from oats/psyllium/linseed (g/day) ^5^   1.7 ± 3.0           2.4 ± 3.5            0.6          −0.4, 1.6     0.21
  Plant sterols (mg/day)                         257 ± 582           604 ± 885            343          74, 611       0.01

^1^ Regression model includes adjustment for recall on weekend/weekday and sex. Coefficient reported for change. Regression model for percentage energy adjusted for recall on weekend/weekday only; ^2^ Energy-dense, nutrient-poor foods classed as discretionary according to the Australian Health Survey discretionary food list \[[@B22-healthcare-04-00075]\]; ^3^ Fruit serve = 150g, vegetable serve = 75g; ^4^ Only grams of soy protein reported as this is posited as the factor having lipid-lowering abilities; ^5^ Only grams of fibre reported as this is posited as the mechanism for lowering serum lipids; Abbreviations: PE, percentage energy; CHO, carbohydrates; sat. fats, saturated fats; mono. fats, monounsaturated fats; poly. fats, polyunsaturated fats; g/day, grams per day; mg/day, milligrams per day.
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###### 

Reported eating habits of foods related to CVD health.

                                   Baseline        Follow up       Χ2
  -------------------------------- --------------- --------------- --------
  Type of milk normally consumed                                   
  Don't drink milk                 7.7 (n = 3)     7.7 (n = 3)     0.08
  Normal/whole/full cream          15.4 (n = 6)    2.6 (n = 1)     
  Reduced fat                      53.9 (n = 21)   41.0 (n = 16)   
  Skim                             12.8 (n = 5)    15.4 (n = 6)    
  Soy                              7.7 (n = 3)     30.8 (n = 12)   
  Other/Not sure                   2.6 (n = 1)     2.6 (n = 1)     
  Type of cheese normally eaten                                    
  Don't eat cheese                 5.1 (n = 2)     5.1 (n = 2)     \<0.01
  Normal/full fat                  56.4 (n = 22)   20.5 (n = 8)    
  Reduced fat                      28.2 (n = 11)   43.6 (n = 17)   
  Low fat                          10.3 (n = 4)    30.8 (n = 12)   
  Type of meat                                                     
  Don't eat meat                   5.1 (n = 2)     5.1 (n = 2)     0.52
  Normal/untrimmed                 38.5 (n = 15)   23.1 (n = 9)    
  Reduced fat/semi-trimmed         35.9 (n = 14)   43.6 (n = 17)   
  Low fat/fully-trimmed            20.5 (n = 8)    28.2 (n = 11)   
  Type of chicken                                                  
  Fried                            2.6 (n = 1)     0 (n = 0)       0.38
  Crumbed                          2.6 (n = 1)     0 (n = 0)       
  With skin                        20.5 (n = 8)    12.8 (n = 5)    
  Skin removed                     74.4 (n = 29)   87.2 (n = 34)   
  Adding salt to food                                              
  Never add salt                   43.6 (n = 17)   51.2 (n = 20)   0.56
  During cooking                   23.1 (n = 9)    23.1 (n = 9)    
  To meals                         23.1 (n = 9)    23.1 (n = 9)    
  Both meals and cooking           10.3 (n = 4)    2.6 (n = 1)     
  Purchasing salt-reduced foods                                    
  Never                            18.0 (n = 7)    12.8 (n = 5)    0.12
  Sometimes                        66.7 (n = 26)   51.3 (n = 20)   
  Always                           15.4 (n = 6)    35.9 (n = 14)   

^1^ Last observation carried forward for person not completing intervention.
